The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 St (Q33438530)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 St
scientific article

    Statements

    The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 St (English)
    Guillaume Charpentier
    Pierre-Yves Benhamou
    Dured Dardari
    Annie Clergeot
    Sylvia Franc
    Pauline Schaepelynck-Belicar
    Bogdan Catargi
    Vincent Melki
    Lucy Chaillous
    Anne Farret
    Jean-Luc Bosson
    Alfred Penfornis
    TeleDiab Study Group
    25 January 2011

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit